Clinical Trial Update: Capecitabine and Oxaliplatin in Adenocarcinoma of the Small Bowel and Ampulla of Vater [Phase 2]

View source ↗

Summary

A Phase 2 trial of capecitabine and oxaliplatin for small bowel adenocarcinoma and ampullary carcinoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ampullary Carcinoma
• Small Bowel Adenocarcinoma

Drugs mentioned

• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Gastrointestinal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-07-14